Different role of CD30 in the development of acute and chronic airway inflammation in a murine asthma model

European Journal of Immunology

Volumn 39, Issue 7, 2009, Pages 1736-1742

  Polte, Tobias ^a,b   Fuchs, Lena ^c   Behrendt, Ann Kathrin ^a   Hansen, Gesine ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Airway remodeling; Asthma; CD30; Costimulation; Th2 cells

Indexed keywords

CD134 ANTIGEN; CD30 ANTIGEN; COLLAGEN; IMMUNOGLOBULIN E; SCLEROPROTEIN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CD3+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ACUTE DISEASE; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; IMMUNOGLOBULIN E; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, OX40; TIME FACTORS;

EID: 69249131747     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200839004     Document Type: Article

References (23)

1. Horie, R. and Watanabe, T., CD30: Expression and function in health and disease. Semin. Immunol. 1998. 10: 457-470.
2. Blazer, B. R., Levy, R. B., Mak, T. W., Panoskaltsis-Mortari, A., Mute, H., Jones, M., Roskos, M. et al., CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease. J. Immunol. 2004. 173: 2933-2941.
3. Tarkowski, M., Expression and a role of CD30 in regulation of T-cell activity. Curr. Opin. Hematol. 2003. 10: 267-271.
4. Gruss, H. J., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F., Hodgkin's disease: A tumor with disturbed immunological pathways. Immunol. Today 1997. 18: 156-163.
5. Bengtsson, A., The role of CD30 in atopic disease. Allergy 2001. 56: 593-603.
6. Polte, T., Behrendt, A. K. and Hansen, G., Direct evidence for a critical role of CD30 in the development of allergic asthma. J. Allergy Clin. Immunol. 2006. 118: 942-948.
7. Polte, T., Foell, J., Werner, C., Hoymann, H. G., Braun, A., Burdach, S., Mittler, R. S. and Hansen, G., CD137-mediated immunotherapy for allergic asthma. J. Clin. Invest. 2006. 116: 1025-1036.
8. Locksley, R. M., Killeen, N. and Lenardo, M. J., The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001. 104: 487-501.
9. Kim, M. Y., Gaspal, F. M., Wiggett, H. E., McConnell, F. M., Gulbranson-Judge, A., Raykundalia, C., Walker, L. S. et al., CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 2003. 18: 643-654.
10. Del Prete, G., De Carli, M, D'Elios, M. M., Daniel, K. C., Almerigogna, F., Alderson, M., Smith, C. A. et al., CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J. Exp. Med. 1995. 182: 1655-1661.
11. Dummer, W., Brocker, E. B. and Bastian, B. C., Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis. Br. J. Dermatol. 1997. 137: 185-187.
12. Polte, T., Jagemann, A., Foell, J., Mittler, R. S. and Hansen, G., CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-γ-producing CD8+ T cells. Clin. Exp. Allergy 2007. 37: 1374-1385.
13. Polte, T., Hennig, C. and Hansen, G., Allergy prevention starts before conception: Maternofetal transfer of tolerance protects against the development of asthma. J. Allergy Clin. Immunol. 2008. 122: 1022-1030, e1025.
14. Lendrum, A. C., Fraser, D. S., Slidders, W. and Henderson, R., Studies on the character and staining of fibrin. J. Clin. Pathol. 1962. 15: 401-413.
15. Humbles, A. A., Lloyd, C. M., McMillan, S. J., Friend, D. S., Xanthou, G., McKenna, E. E., Ghiran, S. et al., A critical role for eosinophils in allergic airways remodeling. Science 2004. 305: 1776-1779.
16. Kallinich, T., Beier, K. C., Gelfand, E. W., Kroczek, R. A. and Hamelmann, E., Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease. Clin. Exp. Allergy 2005. 35: 1521-1534.
17. Jen, K. Y., Jain, V. V., Makani, S. and Finn, P. W., Immunomodulation of allergic responses by targeting costimulatory molecules. Curr. Opin. Allergy Clin. Immunol. 2006. 6: 489-494.
18. Keane-Myers, A. M., Gause, W. C., Finkelman, F. D., Xhou, X. D. and Wills-Karp, M., Development of murine allergic asthma is dependent upon B7-2 costimulation. J. Immunol. 1998. 160: 1036-1043.
19. Burr, J. S., Kimzey, S. L., Randolph, D. R. and Green, J. M., CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am. J. Respir. Cell Mol. Biol. 2001. 24: 563-568.
20. Gonzalo, J. A., Tian, J., Delaney, T., Corcoran, J., Rottman, J. B., Lora, J., Al-garawi, A. et al., ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat. Immunol. 2001. 2: 597-604.
21. Jember, A. G., Zuberi, R., Liu, F. T. and Crok M., Development of allergic inflammation in a murine model of asthma is dependent an the costimulatory receptor OX40. J. Exp. Med. 2001. 193: 387-392.
22. Hoshino, A., Tanaka, Y., Akiba, H., Asakura, Y., Mita, Y., Sakurai, T., Takaoka, A. et al., Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma. Eur. J. Immunol. 2003. 33: 861-869.
23. al-Shamkhani, A., Birkeland, M. L., Puklavec, M., Brown, M. H., James, W. and Barclay, A. N., OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur. J. Immunol. 1996. 26: 1695-1699.